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Background: Chronic hyperglycaemia in diabetes mellitus leads to increased lipid peroxidation in the body, followed by the 
development of chronic complications due to oxidative stress. Objective: The aim of this study was to compare total antioxidant 
(TAO) levels and oxidative stress in type 2 diabetes mellitus (T2DM) patients with that of healthy controls without diabetes. Methods: 
A total of 98 participants (57 T2DM and 41 healthy people) gave their consent and participated in the study. Routine biochemical 
methods were used for fasting plasma glucose (FPG), glycosylated haemoglobin (HbA1c) and lipid profile measurements. Serum 
TAO levels, malondialdehyde (MDA), oxidised low-density lipoprotein (ox-LDL) levels and superoxide dismutase (SOD) activity 
were analysed using standard commercial reagent kits. Results: A significant rise in FPG, HbA1c, triglycerides, MDA and ox-LDL, 
and a significant reduction in TAO and high-density lipoprotein cholesterol (HDL-C) was observed in T2DM patients compared 
with controls. A significant negative relationship was observed between TAO levels and MDA levels in the T2DM group. Increased 
lipid peroxidation and reduced antioxidant levels were observed in T2DM patients. Conclusion: Early management through an 
antioxidant-rich diet and lifestyle changes in T2DM patients would help to avert the debilitating complications of diabetes.
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Introduction
Diabetes mellitus (DM) is a cluster of metabolic disorders 
characterised by abnormally elevated blood glucose levels 
(hyperglycaemia),1 which arise from the body’s inability to 
produce insulin or to use it to its full potential.2 DM is a lifetime 
progressive metabolic disease and, according to recent estimates 
for the year 2015, 415 million adults aged 20–79 suffer from the 
disease worldwide.3 These estimates include 193 million people 
who are undiagnosed and by the year 2040, if the current rate of 
increase in cases continues, 642 million people will be suffering 
from diabetes.3 DM is the fourth primary reason for death by 
disease universally and has become a challenging health 
problem for the twenty-first century.2,4
The incidence of DM is rising at an alarming rate; mainly the type 
2 (non-insulin dependent diabetes mellitus (NIDDM).5,6 Sub-
Saharan Africa, including South Africa, now faces a double 
burden of disease, with an epidemiological transition from 
transmissible diseases to non-communicable or ‘lifestyle’ 
diseases.7,8 The prevalence study by Bertram et al. reported a 
potential rise in type 2 diabetes mellitus in South Africa from 
5.5% in 2000 to 9% in 2009 in people aged 30 or older since the 
previous approximations.9 Secondary studies by Bertram et al. 
furthermore revealed that in South Africa around 55% of cases 
remained undiagnosed.9 In a cross-sectional survey of 642 
participants aged  ≥  31  years from an urban South African 
coloured community in Bellville South, Cape Town, T2DM was 
evaluated using the World Health Organization (WHO) criteria. 
The crude prevalence of T2DM was 28.2%, and undiagnosed 
T2DM was present in 18.1% of participants.10 In a recent report 
by International Diabetic Federation (IDF) on the prevalence of 
diabetes in African countries, South Africa was recorded as 
having an average 2.3 (1.2–4.6) million people with diabetes.3
Several pathological processes are involved in the development of 
diabetes, which range from autoimmune obliteration of the beta 
cell of the pancreas causing insulin deficiency (type 1 diabetes 
mellitus) to abnormalities that result in insulin resistance (T2DM).1 
As a result of chronic hyperglycaemia and insulin resistance, various 
long-term complications of diabetes develop. These complications 
include both microvascular and macrovascular irregularities, such 
as retinopathy, peripheral neuropathy, autonomic neuropathy, 
cardiovascular symptoms and nephropathy.1,11 Oxidative stress is 
accountable for the development of chronic complications of DM12 
and results from chronic hyperglycaemia, dyslipidaemia and 
elevated fatty acids in the circulation.13
Oxidative stress is an inevitable consequence of life in an 
atmosphere that is oxygen-rich14 and arises when a synthesis of 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) 
surpasses the capacity of cellular antioxidant defences to eradicate 
these toxic species. Examples of ROS are superoxide, hydroxyl 
radical, peroxyl radical, and hydroperoxyl radical. The non-radical 
ROS are hydrogen peroxide and hypochlorous acid. Examples of 
RNS include nitric oxide, nitrogen dioxide, peroxynitrite and, 
nitrous oxide.15,16 Most of the free radicals are produced in small 
amounts under normal physiological conditions and scavenged 
by the endogenous antioxidant system. The antioxidant system 
includes enzymes like SOD, catalase, glutathione peroxidase and 
molecules like GSH, uric acid, bilirubin, lipoic acid, albumin, 
transferrin, vitamin E, vitamin C, carotenoid, copper and zinc.17 The 
antioxidants scavenge the free radicals by several mechanisms. 
The enzymes degrade free radicals; proteins such as transferrin 
can bind to metals that stimulate the synthesis of free radicals; and 
vitamins C and E act as free radical scavengers.11 Vitamin C is a 
water-soluble molecule and usually scavenges hydroxyl radicals, 
while vitamin E, a lipid soluble vitamin, interferes with chain 
reactions of lipid peroxidations.11
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participants aged  ≥  31  years from an urban South African 
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evaluated using the World Health Organization (WHO) criteria. 
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diabetes in African countries, South Africa was recorded as 
having an average 2.3 (1.2–4.6) million people with diabetes.3
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In diabetes and other pathological conditions this defence 
mechanism is altered, and ineffective scavenging of ROS and RNS 
plays a vital role in causing tissue damage in the diabetic patient.18 
The increased prevalence of free radicals results in the activation 
of stress-signalling pathways and drains both enzymatic and non-
enzymatic antioxidants, having a negative impact on the quality 
of life and lifespan of the patient. ROS and RNS play a role in 
multiple disease conditions including diabetes and its 
complications.19
Several other mechanisms are also implicated in the generation 
of oxidative stress due to hyperglycaemia in diabetes. These 
mechanisms include glucose auto-oxidation, increased glucose 
flux through the polyol pathway, non-enzymatic and progressive 
glycation of proteins and the formation of advanced glycosylation 
end products (AGEs).20 An increase in the polyol pathway depletes 
the NADPH, which is utilised by the enzyme aldose reductase that 
catalyses the conversion of glucose to sorbitol.2
Numerous studies have reported increased oxidative stress in 
type 2 diabetes mellitus patients compared with their healthy 
counterparts.21,22 In Africa, studies on oxidative stress and diabetes 
have also reported similar findings.23,24 There are very few to no 
studies conducted on oxidative stress levels in South African 
people with type 2 diabetes. This investigation aimed to 
investigate the oxidative stress and total antioxidant levels in 
South African T2DM patients compared with healthy volunteers 
without diabetes.
Materials and methods
Ethical clearance was acquired from the Research Ethics and 
Biosafety Committee, the Faculty of Health Sciences, Walter Sisulu 
University (Bioethics clearance No: 012/012).
Research participant recruitment
Inclusion criteria: The cross-sectional observational study was 
conducted on total of 98 participants (57 black, South African, 
known T2DM patients attending selected diabetes clinics and 41 
healthy volunteers as controls) within the age group 35–75 years, 
all of Xhosa ethnicity, in Mthatha, Eastern Cape Province of South 
Africa.
Exclusion criteria: Patients who have HIV infection and other 
chronic diseases such as tuberculosis, thyroid problems, coronary 
artery diseases, renal complications and other complications of 
diabetes, if reported, were not included in this study.
The clinical examination of the T2DM patients was carried out by 
the clinician of the diabetes clinic. Control participants were 
selected randomly from the general population, keeping in mind 
the selection criteria. The participants were sensitised concerning 
the study, and those who volunteered were asked to sign an 
informed consent form before blood collection. A questionnaire 
was used to obtain anthropometric data as well general 
information (medication, physical activity, family history, duration 
of diabetes and other chronic illnesses) from each participant.
Sample collection and preparation
Fasting blood (approx. 20 ml) was collected in vacutainer tubes 
from each participant. Plasma was separated from the specimen 
within three hours of collection. Serum samples were stored at 
–70 °C if not analysed on the day of collection and used within a 
month. Fasting blood samples were used for measurements of 
plasma glucose, glycated haemoglobin (HbA1c), lipid profile, TAO 
level, malondialdehyde (MDA), thiobarbituric acid reactive 
substances (TBARS), oxidised LDL (ox-LDL) levels and superoxide 
dismutase (SOD) enzyme activity.
Methods
Plasma glucose, HbA1c and lipid profile were measured by routine 
methods, using the Roche cobas® 6000 chemical auto-analyser 
(Roche Diagnostics USA, Indianapolis, IN, USA), by NHLS (National 
Health Laboratory Services) of NMAH (Nelson Mandela Academic 
Hospital). Different methods for assessing lipid peroxidation and 
total antioxidant activity for measuring the oxidative stress in diseases 
have been discussed by various authors.25 In this study the TAO level 
in serum was measured using a Sigma-Aldrich kit (ABTS method; 
Saint Louis, MO, USA). MDA (TBARS) and SOD enzyme activity were 
measured using Cayman assay kits (colorimetric method; Cayman 
Chemical Company, Ann Arbor, MI, USA) and ox-LDL was measured 
by the ELISA technique using a Mercodia kit (Uppsala, Sweden). The 
BioTek KC4 Autoreader (BioTek Instruments, Inc., Winooski, VT, USA) 
was used for all the analyses referred to above.
Statistical analysis
Statistical analysis was conducted using the IBM Statistical 
Package for the Social Sciences, version 23 (IBM Corp, Armonk, NY, 
USA). Data are expressed as mean  ±  SD and median (IQR) 
depending on their distribution (normal and not normal) 
respectively. The statistical significance of differences between 
the means of quantitative variables across groups was evaluated 
by Student’s t-test for normally distributed data, and the non-
parametric Mann–Whitney U test was used for parameters 
violating normal distribution. The bivariate correlations were 
ascertained using Spearman rank correlation to analyse 
relationships between continuous variables.
Results
Table 1 presents information regarding the general characteristics of 
participants. The mean age was comparable across groups and 
showed no significant difference (p = 0.101). The mean BMI for both 
groups was high, with T2DM patients having higher BMIs compared 
with individuals in the healthy control group; the difference was not, 
however, statistically significant (p  =  0.378). Biochemical 
characteristics of participants are presented in Table 2. FPG and 
HbA1c were significantly higher in T2DM patients compared with 
those of persons in the control group (p < 0.0005 and p < 0.0005 
respectively). Serum triglyceride (TG) levels were substantially 
higher in the T2DM group as opposed to the controls (p = 0.024), 
and high density lipoprotein cholesterol (HDL-C) was significantly 
different between groups (p = 0.008), with the T2DM patients having 
lower HDL-C compared with the persons in the healthy control 
group. There was no difference in total cholesterol (TC) and low 
density lipoprotein cholesterol (LDL-C) between the two groups.
Serum TAO, MDA (TBARS) and ox-LDL levels were significantly 
different in both groups. A statistically significant reduction in 
Table 1: Demographic characteristics of diabetic and control participants
Notes: Data are shown as mean ± SD and median (IQR), BMI = body mass 
index.
Parameters Control group, 
n = 41
T2DM group,  
n = 57
p-value
Age (years) 54.24 ± 6.05 56.61 ± 7.59 0.101
Weight (kg) 76.0 (87.8−65.7) 80.0 (96.0−70.0) 0.125
Height (cm) 159.4 ± 6.20 162.1 ± 7.87 0.067
BMI (kg/m2) 30.4 ± 7.28 31.6 ± 6.49 0.378
Duration of diabe-
tes (years) – 6.87 ± 6.34
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TAO levels was observed in the T2DM patients compared with 
healthy participants (p = 0.017), whereas median MDA and ox-
LDL levels were significantly raised in patients with diabetes 
compared with controls. There was no significant difference in 
total SOD activity between the two groups, as shown in Table 3.
An analysis of the correlations between HbA1c, MDA, ox-LDL, 
SOD and TAO in both groups is shown in Table 4. There was a 
significant negative correlation between TAO levels and MDA in 
the T2DM group (r = 0.291, p = 0.029). There was also a significant 
negative correlation between HDL-C and HbA1c, TG and ox-LDL 
levels in the control group, whereas in the T2DM patients only TG 
levels were significantly associated with HDL-C, as presented in 
Table 5.
Discussion
In the present study there was a marked rise in HbA1c and FPG 
levels in T2DM patients compared with the control population, 
indicating excessive glycosylation of haemoglobin and poor 
control of diabetes as reported by other studies.23,26–29 An increase 
in the serum TG levels and a decrease in HDL-C levels were 
observed in patients with diabetes, indicating the presence of 
dyslipidaemia. Since the uptake of free fatty acids (FFAs) by the 
skeletal muscle and adipose tissue is mediated by insulin, an 
increase in insulin resistance would result in increased FFAs 
delivered to the liver. This leads to the overproduction of very 
low-density lipoprotein (VLDL) and increased VLDL–cholesterol 
concentrations, clinically manifesting as hypertriglyceridemia. An 
accumulation of the TG-rich lipoproteins in plasma can also result 
due to decreased lipoprotein lipase (LpL) activity.30 
Hypertriglyceridemia and reduced plasma HDL-C is commonly 
present in T2DM and has been reported by various studies.28,29,31
Chronic hyperglycaemia, dyslipidaemia and elevated FFAs results 
in oxidative stress by stimulating ROS and RNS production,13 
which attacks the lipids found in the plasma membranes, 
mitochondrial membranes and endoplasmic reticulum 
membranes and causes peroxidation.32 Once lipid peroxidation is 
initiated, propagation chain reactions will occur until termination 
products are produced, such as lipid hydroperoxide, which 
further decompose to aldehydes such as MDA and, 4-hydroxy-2 
nonenal (4-HNE). Cyclic endoperoxides, isoprostanes and 
hydrocarbons may also be formed.18,33–38 The observed increase in 
MDA levels in T2DM patients in the present study is thought to be 
due to the increased production of lipid peroxides and their 
release in circulation, which would be consistent with previous 
studies.21–23,39 In the present study, increased oxidation of LDL 
particles was observed in the T2DM patients compared with the 
control group. Several factors, such as glycation, increased TG 
content and the reduced anti-oxidative properties of HDL are 
possible stimulators of LDL oxidation in T2DM patients.40 TGs have 
an effect on LDL size and HDL-C inhibits the oxidative modification 
of LDL, so increased TG and decreased HDL-C can result in further 
oxidation of LDL in diabetes.27 Similar observations have been 
reported by other studies.41–43
A significant decrease in TAO levels among T2DM patients was 
observed in this study and has also been reported by various 
other authors in their studies.21,23,42 This reduction in TAO levels 
could be attributed to increased oxidative stress. This is evidenced 
by increased lipid peroxidation as well as by the excess utilisation 
of antioxidants against oxidative stress to minimise the damage. 
The significant negative correlation observed between TAO levels 
and MDA levels in the T2DM group in this study also explains the 
decrease in TAO levels with increased lipid peroxidation. Jamuna 
Table 2: Biochemical characteristics of diabetic and control participants
Notes: Data are shown as mean ± SD and median (IQR), FPG = fasting 
plasma glucose; HbA1c = glycated haemoglobin, TC = total cholesterol; 
TG = triglyceride; HDL-C = high density lipoprotein cholesterol; LDL-C = 
low density lipoprotein cholesterol. The median and mean difference is 
significant at *p < 0.05 and **p < 0.005 level.
Parameters Control group, 
n = 41
T2DM group,  
n = 57
p-value 
FPG (mmol/L) 4.9 (5.2 − 4.6) 8.1(10.7−5.90) < 0.0005**
HbA1c (%) 6.0 (6.2−5.8) 8.5 (10.2−6.9) < 0.0005**
Haemoglobin (g 
/dl) 14.1 ± 1.49 14.1 ± 1.44 0.854
TC (mmol/L) 4.70 ± 0.92 4.51 ± 1.23 0.420
TG (mmol/L) 1.10 (1.55−0.90) 1.30 (2.05−1.07) 0.024*
HDL-C (mmol/L) 1.40 (1.55−1.10) 1.16 (1.40−1.0) 0.008*
LDL-C (mmol/L) 2.72 ± 0.88 2.57 ± 1.03 0.461
Table 3: Antioxidant status and lipid peroxidation in diabetic and control 
participants
Notes: Data are shown as mean ± SD and median (IQR). The mean and 
median difference is significant at *p < 0.05, and **p < 0.005 level. TAO = 
total antioxidant; SOD = superoxide dismutase; MDA = malondialdehyde; 
ox-LDL= oxidised LDL.
Parameters Control group, 
n = 41
T2DM group,  
n = 57
p-value
TAO (mM) 0.60 (0.80−0.44) 0.48 (0.61−0.37) 0.017*
Total SOD activity 
(U/ml) 3.19 (4.68−2.53) 4.01(5.26−3.0) 0.096
MDA (μM) 3.43 (4.75−2.42) 4.33 (5.75−3.29) 0.004**
Ox-LDL (U/L) 77.5 (107.4−56.2) 95.9 (137.6−65.2) 0.022*
Table 4: Spearman’s correlation between HbA1c, MDA, ox-LDL and SOD 
activity and TAO level in diabetic and control participants
Notes: Data are presented as Spearman correlation coefficient (r), 
*p < 0.05. MDA = malondialdehyde; SOD = superoxide dismutase; ox-LDL 
= oxidised LDL; HbA1c = glycated haemoglobin; TAO = total antioxidant.









trol group 0.141 −0.286 −0.053 −0.221
TAO in T2DM 
group −0.291* −0.251 −0.229 −0.103
Table 5: Spearman’s correlation between HbA1c, triglyceride, ox-LDL 
levels and HDL cholesterol in diabetic and control participants
Notes: Data are presented as Spearman correlation coefficient (r), 
*p < 0.05 and **p < 0.005 levels. Ox-LDL = oxidised LDL; HbA1c = 
glycated haemoglobin; HDL-C = high density lipoprotein cholesterol.
Groups Triglyceride  
r-value
Ox-LDL r-value HbA1c r-value
HDL-C in control 
group −0.361* −0.594** −0.325*
HDL-C in T2DM 
group −0.391* −0.087  0.047
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glycated haemoglobin; HDL-C = high density lipoprotein cholesterol.
Groups Triglyceride  
r-value
Ox-LDL r-value HbA1c r-value
HDL-C in control 
group −0.361* −0.594** −0.325*
HDL-C in T2DM 
group −0.391* −0.087  0.047
24 Journal of Endocrinology, Metabolism and Diabetes of South Africa 2017; 22(2):21–25
4.  Maiese K, Daniela Morhan SD, Zhong Chong ZZ. Oxidative stress biology 
and cell injury during type 1 and type 2 diabetes mellitus. Curr Neuro 
Res. 2007;4(1):63–71. https://doi.org/10.2174/156720207779940653
5.  Levitt NS, Bradshaw D, Zwarenstein MF, et al. Audit of public sector 
primary diabetes care in Cape Town, South Africa: high prevalence 
of complications, uncontrolled hyperglycaemia, and hypertension. 
Diabet Med. 1997;14:1073–7. https://doi.org/10.1002/(ISSN)1096-
9136
6.  Jakus V. The role of free radicals, Oxidative stress and antioxidant 
systems in diabetic vascular disease. Bratisl lek listy. 2000;101(10):541–
51.
7.  Gning SB, Thiam M, Fall F, et al. Diabetes mellitus in sub-Saharan Africa: 
epidemiological aspects and management issues. Med Tropicale 
(Mars). 2007;67(6):607–11.
8.  Mayosi BM, Flisher AJ, Lallo UG, et al. The burden of non-communicable 
disease in South Africa. Lancet. 2009;374(9694):957–9.
9.  Bertram MY, Jaswal AVS, Pillay Van Wyk V, et al. The non-fatal disease 
burden caused by type 2 diabetes in South Africa, 2009. Global Health 
Action. 2013;6:206–12. doi:10.3402/gha.v6i0.19244.
10.  Erasmus RT, Soita DJ, Hassan MS, et al. High prevalence of diabetes 
mellitus and metabolic syndrome in a South African coloured 
population: baseline data of a study in Bellville, Cape Town. South Afr 
Med J. [internet]. 2012 [cited 2016 Apr 30];102(11):841–4. ISSN 2078-
5135. Available from: http://www.samj.org.za/index.php/samj/article/
view/5670/4761. doi:10.7196/SAMJ.5670.
11.  Rahimi R, Nikfar S, Larijani B, et al. A review on the role of antioxidants in 
the management of diabetes and its complications. Biomed Pharma. 
2005;59(7):365–73. https://doi.org/10.1016/j.biopha.2005.07.002
12.  Opara EC. Oxidative stress, micronutrients, diabetes mellitus and its 
complications. J Royal Soc Promot Health. 2002;122(1):28–34. https://
doi.org/10.1177/146642400212200112
13.  Kuroki T, Isshiki K, King GL. Oxidative stress: the lead or 
supporting actor in the pathogenesis of diabetic complications. 
J Am Soc Nephrol. 2003;14:S216–20. https://doi.org/10.1097/01.
ASN.0000077405.07888.07
14.  Davies KJA. Oxidative stress, antioxidant defences and damage 
removal, repair and replacement systems. Int Union Biochem Mol Biol 
Life. 2000;50:278–89.
15.  Johansen JS, Harris AK, Rychly DJ, et al. Review, oxidative stress and 
the use of antioxidants in diabetes: Linking basic science to clinical 
practice. Cardiovas Diabetol. 2005;4:5. https://doi.org/10.1186/1475-
2840-4-5
16.  Limón-Pacheco J, Gonsebatt ME. The role of antioxidants 
and antioxidant-related enzymes in protective responses to 
environmentally induced oxidative stress. Mutation Res. 2009;674: 
137–47. https://doi.org/10.1016/j.mrgentox.2008.09.015
17.  Maiese K, Chong ZZ, Shang YC. Mechanistic insights into diabetes 
mellitus and oxidative stress. Curr Med Chem. 2007;14(16):1729–38.
18.  Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in 
normal physiological functions and human disease. Int J Biochem Cell 
Biol. 2007;39:44–84. https://doi.org/10.1016/j.biocel.2006.07.001
19.  Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the 
oxidative stress theory of diabetic neuropathy. Rev Endocrine Metab 
Disord. 2008;9(4):301–14. https://doi.org/10.1007/s11154-008-9104-2
20.  Mossanda KS, Bolajoko EB, Morapane M, et al. Antioxidant and 
oxidative stress status in type 2 diabetes and diabetic foot ulcer. 
JEMDSA. 2008;13(2):58–63.
21.  Jamuna Rani A, and Mythili SV. Study on total antioxidant status in 
relation to oxidative stress in type 2 diabetes mellitus. J Clin Diagn Res. 
2014;8 (3):108–10.
22.  Maharjan BR, Jha JC, Adhikari D, et al. A study of oxidative stress, 
antioxidant status and lipid profile in diabetic patient in western 
region of Nepal. Kathmandu Univ Med J. 2008;(6):16–22.
23.  Benrebai M, Abidli N, Nasr SM, et al. Oxidative stress status in type 
2 diabetic patients in Eastern Algeria. World Appl Sci J. 2008;4(5): 
714–9.
24.  Soliman GZA. Blood lipid peroxidation (superoxide dismutase, 
malondialdehyde, glutathione) levels in Egyptian type 2 diabetic 
patients. Singap Med J. 2008;49(2):129–36.
25.  Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid 
peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta. 
2001;306:1–17. https://doi.org/10.1016/S0009-8981(01)00393-X
Rani and Mythili showed a significant negative association 
between TAO levels and MDA levels in their study population.21 
There was no significant difference in total SOD activity between 
the two groups, which concurs with the findings of Kesavulu et al. 
and Gurler et al. in their studies of T2DM patients.44,45
A significant negative correlation was observed between HDL-C 
and serum TG in the T2DM patients and the control participants. 
In the T2DM group, no significant correlation was demonstrated 
between HDL-C and ox-LDL, but the control group showed a 
significant negative correlation. HDL-C contains enzymes such as 
paraoxonase, platelet activating factor, acetylhydrolase, and 
lecithin cholesterol acyltransferase and is involved in the reverse 
transport of cholesterol from the periphery to the liver. These 
enzymes prevent the formation of or metabolise the oxidised 
phospholipids. Evidence exists that HDL can reverse LDL oxidation 
by removing the oxidised phospholipids that make LDL harmful 
and lead to atherogenesis.46 In the healthy control group, a 
significant negative association was observed between the HDL 
and LDL, which indicates that high HDL-C can decrease the 
oxidation of LDL. In the T2DM group, this correlation was not 
significant and could be due to the fact that in diabetes the anti-
oxidative property of HDL is reduced. This reduction could be 
promoted by hyperglycaemia and the TG enrichment of 
lipoprotein.40 This may be the reason why no correlation was 
observed between HDL-C and ox-LDL in the T2DM group.
Conclusion
The results of this study suggest that hyperglycaemia and 
dyslipidaemia seen in the T2DM patients could lead to an increase 
in lipid peroxidation and oxidative stress and thus a decrease in 
TAO levels. This decrease in TAO levels could be due to its 
increased utilisation in order to scavenge the free radicals 
produced in high amounts due to increased oxidative stress. Early 
intervention and a diet rich in antioxidants can reduce the risk of 
developing complications and increase the longevity and quality 
of life of patients with diabetes.
Limitations
The effects of diet and diabetic medication were not considered 
in the study.
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